Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Susceptibility Mapping Biomarker, Brain Structure and Connectome Associated With Cerebral Cavernous Malformation Related Epilepsy and Outcome After Surgery

NCT04076449 is registered in ClinicalTrials.gov with yuanli Zhao as lead sponsor.

NCT NCT04076449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04076449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Susceptibility Mapping Biomarker, Brain Structure and Connectome Associated With Cerebral Cavernous Malformation Related Epilepsy and Outcome After Surgery
Lead sponsor
yuanli Zhao
Phase
Observational
Overall status
Recruiting
Start date
September 3, 2019
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cavernous angioma, cavernous hemangioma, cavernous hemangioma of brain, cavernous malformation, cerebral, epilepsy, seizures, seizures, epileptic